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We report a novel CFTR mutation in a Czech infant. An 8 weeks old boy came
because IRT elevation (118 ng/ml). Scoring of 50 CFTR mutation was provided
using commercially available test Elucigene CF-EU2. Mutation F508del on one
CFTR allele was detected. Sweat chloride was repeatedly higher (50.5; 55.3mmol/l).
The boy was born healthy with birth weight 3 600 g. A prolonged icterus with
fototherapy followed. The child was pancreatic sufﬁcient and gained well. No
respiratory symptoms were involved. A pathological ﬂora from upper respiratory
tract was repeatedly present: Haemophilus inﬂuenzae, Staphylococcus aureus,
Streptococcus pneumoniae. That why the genetic testing went on screening for
rare and unknown mutation in the whole coding sequence of the CFTR gene
to the 27 exons and their exon-intron boundaries using direct sequencing. This
approach enabled us to identify the novel missense mutation c.2863T>C (S955P)..
The patient was a compound heterozygote, the mutation c.2863T>G was inherited
from his mother, and the F508del mutation from his father. This novel mutation
is located in exon 17, which belongs to membrane spanning domain 2 (MSD2),
which is implicated in forming the pore of the channel, and the corresponding CFTR
variants retain normal amount of CFTR with some residual function at the apical
membrane. Mutations in MSD2 are typically associated with a milder pancreatic
phenotype (PS). Nevertheless, there is needed a consequential classiﬁcation of this
novel mutation based on its potential for causing disease and their implication for
genetic counseling, that is, prenatal diagnosis and carrier testing.
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Introduction: p.Leu206Trp mutation (frequency <1%) is associated with residual
transmembrane transport of chloride and mild CF.
Objective: To analyze the clinical status of patients with CF with compound
heterozygosity for the p.Leu206Trp mutation.
Methods: Clinical retrospective data of 12 patients (6 males, age range 4 months
to 12 years) with p.Leu206Trp and other CFTR mutations were examined. Sweat
test (ST) values at different ages, pulmonary function, pancreatic sufﬁciency
(PS), clinical symptoms, air trapping (AT) on CT scan and colonization with
Pseudomonas aeruginosa (PA) or Staphyloccocus aureus (SA) were analyzed.
Results: All patients were diagnosis by newborn screening (NS). p.Leu206Trp
frequency was 4.2% (sample of 280 CF alleles).
Other CFRT mutations were: 7 patients with p.Phe508 del, 2 with p.Gly542, 1 with
p.Asn1303Lys, 1 p.ile507del and 1 with 711+1G>T.
SC values (Cl− [mmol/L]) at diagnosis and at present time were: 35/73; 45/83;
52/82; 45/80; 52; 53/73; 55/59; 45/56; 51/57; 66/68; 58/72 and 50 respectively.
The ST values were borderline at NS period (except in one) but became positive
with increasing age. All FEV1 predicted values were normal. SA and PA were
isolated occasionally. AT on CT were present in 5 patients All the patients except
one showed PS.
Conclusions: Patients with p.Leu206Trp in heterozygous state are associated with
mild disease. Despite normal FEV1, AT was present in some patients and correlated
with low values of small airways. We found a high prevalence of this mutation in
our series. p.Leu206Trp should be analyzed in patients with one identiﬁed mutation
and bordeline ST values at NS.
11 Original description of a large 6b−16 exon duplication in
CFTR gene in a Brazilian CF patient
X.P. Pepermans1, F.A. Ribeiro2, C. Bertuzzo3, T. Leal4. 1Universite´ Catholique
de Louvain, Center for Human Genetics, Brussels, Belgium; 2Faculty of Medicine,
Pediatrics, Unicamp, Campinas, Brazil; 3Faculty of Medecine, Center for Human
Genetics, Unicamp, Campinas, Brazil; 4Universite´ Catholique de Louvain, Center
for Toxicology and Applied Pharmacology, Brussels, Belgium
Objectives: The vast majority of CFTR mutations correspond to single base-
pair substitutions or small deletion/insertion defects. Large rearrangements account
for 1−3% of the CFTR mutations and 14−26% of unidentiﬁed alleles remain
uncharacterized. This work reports on the original description of a new DNA
rearrangement identiﬁed in a patient displaying classic CF disease and heterozygous
for the F508del mutation.
Methods: The new large CFTR rearrangement identiﬁed by MLPA was
deposited in the CF mutation Database by Pepermans et al. under
the c.DNA name of c.(?_744)_(2988_?)dup (http://www.genet.sickkids.on.ca/
MutationDetailPage.external?sp=1923; 2010-09-23). It corresponds to a duplication
of 70 kb encompassing exons 6b to 16. The mutation was identiﬁed in a 14 year old
Brazilian girl, diagnosed by age of 9 years with digestive and respiratory symptoms
and failure to thrive (weight and height below the 5th percentile). The patient
has an elevated sweat test (Cl between 94 and 117mmol/L), oxygen-dependent
pulmonary disease with chronic colonization by Pseudomonas aeruginosa and
exocrine pancreatic insufﬁciency. The c.744-?_2988+?dup duplication has been
recently recognized in an Italian patient also presenting classic CF and severe
disease phenotype.
Conclusion: The new large duplication we originally identiﬁed in a Brazilian patient
carrying an F508del mutation was associated with a classic CF disease displaying
a severe respiratory and digestive phenotype. The exact genomic breakpoint of the
duplication is under investigation.
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Objectives: Correlation between clinics characteristics and genotype of the ﬁrst 10
children diagnosed by NBS.
Method: NBS between June 2010 and December 2011 in 78.404 newborn were done,
44 with NBS positive were refereed to CF Unit for clinic evaluation and sweat tests
to conﬁrmation or exclusion diagnosis. In cases of positives or borderline, sweat tests
mutations analyses were performed. The disease was conﬁrmed in 10 children. Clinics
records were retrospective analyzed and age, sex, nutritional evaluation, symptoms,
pancreatic sufﬁciency and genotype correlation.
Results: The disease was diagnosed in 10 children aged between 14 days and 14 months
(median: 2 months), 6 boys and 4 girls. The nutritional state in 5 children was
normal, 4 had severe underweight and growth retardation and 1 had slight growth
retardation. 4 patients didn’t present symptoms. 3 had digestive symptoms and 4
presented respiratory symptoms. 9 patients presented pancreatic insufﬁciency. It was
found that 4 patients were homozygous for DF508 mutation. 4 were heterozygous
for DF508, 3 of them had a complementary mutation (3120 + 1G>A, N1303K and
R1162X respectively), no other mutation were found in the other child. The other 2
children presented just one mutation (2789 + 5G>A and R117H5T−7T).
Conclusions: The most frequent mutation found was homozygous and heterozygous
for DF50 8. Just one patient had pancreatic sufﬁciency, the others were insufﬁciencies,
and this fact would have a vinculation with the most frequent mutation found. Half of
the children had a severely affected nutritional state and they further presented early
severe symptoms remaining hospitalized since their birth.
